Efecto de la menopausia en pacientes con microprolactinomas / Evolution of Microprolactinomas after Menopause

Introducción: El papel estimulante de los estrógenos sobre la secreción de prolactina y sobre la proliferación de los lactotropos está bien establecido. Hay escasa literatura sobre los efectos de la menopausia en pacientes con prolactinomas. Objetivos: Evaluar la evolución del tamaño del tumor y de los niveles plasmáticos de prolactina (PRL) en pacientes con microprolactinomas diagnosticados y tratados con agonistas dopaminérgicos (AD) durante su edad fértil y los efectos de la suspensión del tratamiento después de la menopausia. Materiales y métodos: Estudio retrospectivo, multicéntrico. Veintiún pacientes con microprolactinomas diagnosticados durante su edad fértil fueron estudiados en la menopausia. La edad media ± SD de la menopausia fue de 49 ± 3,6 años. En todas las pacientes se suspendió el tratamiento en la menopausia. Resultados: El nivel de PRL pretratamiento fue de 120 ± 58 ng/ml (media±SD) durante la menopausia, al suspender el tratamiento antes de los 12 meses de 23 ± 14 ng/ml y después de 12 meses o más de 1 año de 16 ± 6 ng / ml. Durante la menopausia y al suspender el tratamiento, el tumor desapareció en 9/21 y disminuyó en 12/21 pacientes; un año o más de un año después de la suspensión del tratamiento, el tumor desapareció en 9 /12 y se mantuvo sin cambios en 3/12. La duración promedio del tratamiento fue de 135 ± 74 meses. Dos pacientes reiniciaron el tratamiento debido a que los niveles de PRL aumentaron. Conclusiones: En la mayoría de las pacientes estudiadas se normalizaron los niveles plasmáticos de prolactina y se observó una disminución o desaparición de los microprolactinomas. Los AD podrían suspenderse después de la menopausia en pacientes microprolactinomas. Rev Argent Endocrinol Metab 51:136-141, 2014 Los autores declaran no poseer conflictos de interés.

Introduction: The stimulatory role of estrogens on prolactin secretionn and on proliferation of lactotropic cells is well-established. There is scarce literature about the effects of menopause in patients with prolactinomas. Objectives: To assess the evolution of tumor size and prolactin (PRL) levels in patients with microprolactinomas diagnosed and treated with dopamine agonists bromocriptine (BEC)/cabergoline (CAB) during their fertile age and the effects of discontinuation of those drugs after menopause. Material and methods: retrospective, multicenter study. Twenty-one patients diagnosed with microprolac­tinomas during their fertile age were studied in their menopause. Mean ± SD age at menopause was 49±3.6 years. In all patients, treatment was stopped when they reached menopause. Results: Mean ± SD pre-treatment PRL level was 120 ± 58 ng/ml and during menopause after stopping treatment, it was 23 ± 14 ng/ml before 12 months, and 16 ± 6 ng/ml after 12 months. During menopause and when stopping treatment, the tumor disappeared in 9/21 and the tumor size decreased in 12/21 patients; a year or more after treatment discontinuation, the tumor disappeared in 9/12 and was unchanged in 3/12. The mean ± SD treatment duration was 135 ± 74 months. Two patients were restarted on treatment because PRL levels increased. Conclusions: Normal PRL levels and sustained reduction or resolution of adenomas were achieved in most patients studied. Only two out of 21 restarted treatment because of hyperprolactinemia. Dopamine agonists might be safely stopped after menopause in patients with microprolactinomas. Rev Argent Endocrinol Metab 51:136-141, 2014 No financial conflicts of interest exist.

Primary empty sella (PES): a review of 175 cases.

The term primary empty sella (PES) makes reference to the herniation of the subarachnoid space within the sella turcica in patients with no history of pituitary tumor, surgery or radiotherapy. To retrospectively assess clinical features, radiological findings and the biochemical endocrine function from the records of 175 patients with a diagnosis of PES. One hundred seventy-five patients (150 females) were studied. The mean age at diagnosis was 48.2 ± 14 year. Most diagnoses were made by magnetic resonance imaging (n = 172). In most patients, the pituitary function was assessed by basal pituitary hormones measurements. Pituitary scans were ordered for different reasons: headache (33.1 %), endocrine disorders (30.6 %), neurological symptoms (12.5 %), visual disturbances (8.75 %), abnormalities on sella turcica radiograph (8.75 %) and others (6.25 %). Multiple pregnancies were observed in 58.3 % of women; headaches, obesity, and hypertension were found in 59.4, 49.5, and 27.3 % of the studied population, respectively. Mild hyperprolactinemia (<50 ng/ml) was present in 11.6 % of women and 17.3 % of men. Twenty-eight percent of our patients had some degree of hypopituitarism. In the male population, hypopituitarism represented 64 % of cases, whereas it accounted for 22 % of all females. PES seems to be more commonly found in middle-aged women, with a history of multiple pregnancies. In most patients, PES was discovered as an incidental finding on imaging studies, while in almost a quarter of patients PES was found during the diagnostic evaluation of anterior pituitary deficiency, which was more common in men.

Silla turca vacía primaria (STVP): estudio de 117 casos / Primary Empty Sella (PES): A review of 117 cases

Introducción: El término Silla Turca Vacía Primaria (STVP) hace referencia a la invaginación del espacio subaracnoideo hacia el interior de la silla turca en pacientes sin antecedentes de tumor, cirugía o radioterapia de la región selar. Aunque usualmente no está asociado con disfunciones endocrinas, diferentes grados de hipopituitarismo e hiperprolactinemia han sido reportados. Objetivo: Analizar retrospectivamente datos clínicos, hallazgos radiológicos y bioquímicos de 117 pacientes con diagnóstico de STVP. Pacientes y Métodos: Se estudiaron 117 pacientes, 98 mujeres (48 ± 14.9 años). Los diagnósticos fueron realizados por Resonancia Magnética Nuclear (n=115) y Tomografía Computada (n=2). La evaluación de la función adenohipofisaria se realizó a través de determinaciones hormonales basales. Resultados: Los motivos que llevaron al pedido de las imágenes fueron: cefaleas (35 %), sospecha clínica y/o bioquímica de deficiencia pituitaria (22 %), trastornos visuales (11 %), anormalidades de la radiografía simple de la silla turca (11 %), hiperprolactinemia (2,6 %), otros (18.4 %). El 48,9 % de las mujeres eran multíparas. Cefaleas, obesidad, hipertensión arterial y autoinmunidad tiroidea fueron halladas en el 60, 67, 24,5 y 22,5 % de la población evaluada respectivamente. Hiperprolactinemia (< 50 ng/ml) estuvo presente en 6,1 % de las mujeres y 15, 8 % de los hombres. El 27 % de los pacientes estudiados presentó algún grado de hipopituitarismo, que fue más frecuente en la población masculina. Conclusiones: STVP fue más frecuente en mujeres multíparas de mediana edad. En la mayoría de los casos fue descubierta incidentalmente por estudios radiológicos, mientras que en un cuarto de los pacientes, fue encontrada durante la evaluación diagnóstica de deficiencia adenohipofisaria, lo cual fue más frecuente en hombres.

Introduction: The term Primary Empty Sella (PES) makes reference to the herniation of the subarachnoid space within the sella turcica in those patients with no history of pituitary tumor, neither surgery, nor radiotherapy. Though it is usually not associated with endocrine abnormalities, different degrees of hypopituitarism and mild hyperprolactinemia have been reported. Objective: To assess clinical features, radiological findings and biochemical endocrine function retrospectively from the records of 117 patients with diagnosis of PES. Patients and Methods: One hundred seventeen patients, 98 females, were studied. The mean age at diagnosis was 48 ± 14.9 yr. Most diagnoses were made with magnetic resonance imaging (n = 115), and only 2 through sellar computed tomography scan. Only pituitary basal hormones determinations were made, except for the TRH and ACTH tests which were performed for the diagnosis of primary hypothyroidism and secondary adrenal failure respectively. Results: Pituitary images were requested because of different reasons: headaches (35 %), clinical and biochemical suspicion of pituitary deficiency (22 %), visual disturbances (11 %), abnormalities on the simple sella turcica radiography (11 %) hyperprolactinemia (2.6 %), others (18.4 %): dizziness, seizures, rhinorrhea, loss of consciousness, skull trauma, galactorrhea. Multiple pregnancies were observed in 48.9 % of women; headaches, obesity, arterial hypertension and thyroid autoimmunity were found in 60 %, 67 %, 24.5 % and 22.5 % of the studied population respectively. Mild hyperprolactinemia (< 50 ng/ml) was present in 6.1 % of women and 15.8 % of men. Twenty seven percent of our patients had some degree of hypopituitarism. For male population hypopituitarism comprised 72 %, whereas it took up 19 % for the whole female group. Conclusions: PES seems to be more commonly found in middle-aged women (sex ratio 5/1) with history of multiple pregnancies. In most patients it was discovered as an incidental finding at image studies, while in almost a quarter of patients PES was found during the diagnosis stage of anterior pituitary deficiency, which was more frequently seen among men.

Acromegalia: comparación de los niveles séricos de IGF-I por dos inmunoensayos y su correlación con la prueba de tolerancia oral a la glucosa / Acromegaly: Comparison of serum IGF-1 levels measured by two immunoassays and their correlation with the Oral Glucose Tolerance Test

Introducción: La determinación de IGF-I en suero o plasma es una herramienta esencial en el diagnóstico y seguimiento de la acromegalia. Sin embargo, se deben tener presentes algunos inconvenientes en su medición por diferentes inmunoensayos. Objetivos: Evaluar dos inmunoensayos para la determinación de IGF-I y su correlación con el nadir de GH en el TTOG en pacientes acromegalicos. Materiales y métodos: Se analizaron 37 pacientes acromegálicos, 20 mujeres y 17 hombres. IGF-I fue determinada por Immulite 1000, (IMM) y por IRMA (DSL). Se realizó el TTOG y se determinó glucosa y GH en todos los tiempos (basal, 30, 60, 90 y 120min). Se consideró respuesta normal un nadir de GH <1ng/ml. Nueve pacientes se encontraban bajo tratamiento y 28 sin tratamiento. Análisis estadístico: se utilizaron el test de Wilcoxon, de Bland y Altman y curvas ROC. Se consideró significativa una p<0,05. Resultados: Las concentraciones basales de glucosa fueron 97,86±10,91 mg/dl, de GH 2,8 (1,59-14,4) ng/ml, de IGF-I por IMM 602±318 ng/ml y por DSL 1006±596 ng/ml. IGF-I por IMM y DSL mostró una diferencia significativa con p <0,01 y un bias de - 403,2 ng/ml con valores menores por IMM. IGF-I elevada por IMM y DSL, se encontró en el 84% y en el 97% respectivamente. IGF-I elevada con nadir de GH >1ng/ml se encontró en el 70%, con nadir de GH normal en el 13,5%. IGF-I normal con nadir >1ng/ml en el 2,7% y con nadir de GH normal en el 13,5%. El área bajo las curvas ROC no mostró diferencias significativas. Conclusiones: Los niveles de IGF-I determinados por IMM y DSL fueron significativamente diferentes mostrando un bias negativo para IMM. La mayoría de los valores del nadir de GH fueron consistentes con los niveles de IGF-I observándose una discrepancia en el 30% de los pacientes, estuvieran o no bajo tratamiento.

Introduction: IGF-I determination in serum or plasma is an essential tool in the diagnosis and follow-up of acromegaly. Hepatic production of IGF-I is regulated by GH and circulates bound to several IGF-I binding proteins which extends its half life. IGF-I is not released in a pulsatile pattern and has no significant variability in 24 h. Objective: To evaluate two different methodologies in IGF-I levels determination and their correlation with GH nadir in OGTT in acromegalic patients. Material and methods: We analyzed 37 acromegalic patients, 20 women and 17 men, mean age was 45±12 years. IGF-I levels were assayed by Immulite 1000, DPC (IMM) and DSL-5600 ACTIVE® IGF-I Coated-Tube IRMA (DSL) and OGTTs (at baseline and at 30, 60, 90 and 120 minutes) were performed by measuring plasma glucose and GH assay by immunochemiluminometric assay (Access); we considered a nadir <1ng/ml as normal response. Nine patients were under medical treatment (cabergoline: 4, octeotride: 4, and cabergoline plus octeotrite: 1) and 28 without treatment. Statistical analysis: Wilcoxon and, Bland and Altman tests and ROC curves. Differences were considered significant at p< 0.05. Results: Basal glucose levels were 97.86±10.91 mg/dl and mean GH was 2.8 (1.59-14.4) ng/ml. Mean IGF-I levels performed by IMM were 602±318 ng/ml and 1006±596 ng/ml by DSL. There was a statistically significant difference between both methodologies (p<0.01). Bland and Altman test showed a bias of - 403.2 ng/ml with lower values by IMM. We observed elevated IGF-I levels in 84% by IMM and in 97% by DSL, and only one patient had normal levels with both methodologies. Elevated IGF-I levels and GH nadir >1ng/ml were observed in 70% of the patients, increased IGF-I with normal GH nadir in 13.5%, normal IGF-I with GH nadir >1ng/ml in 2.7% and normal IGF-I with normal GH nadir in 13.5%. Patients under treatment: 3 showed normal GH nadir with elevated IGF-I levels, in 2 of them by both methodologies, and in the other one it was normal by IMM and elevated by DSL; the other 6 showed GH nadir > 1ng/ml, 5 of them presented elevated IGF-I by both methodologies and the other one showed discrepancy in IGF-I levels. The under ROC curve area and confidence interval (CI) of 95% for IGF-I IMM and DSL were 0.96 (0.90-1.00) and 0.91 (0.82-1.00) respectively. Differences between the ROC curves areas were not significant Conclusions: IGF-I levels determined by IMM and DSL were statistically significantly different. IGF-I levels showed a negative bias by IMM. Most of the results of GH nadir were consistent with IGF-I levels but we observed discrepancy in 30% of the patients, regardless of whether they were under treatment or not.

Estudio retrospectivo sobre las posibles complicaciones maternofetales de la exposición a cabergolina / Retrospective Study of any potencial Adverse Effects of Cabergoline on Pregnancy and Embryofetal Development

Objetivos: Estimar la frecuencia de complicaciones maternofetales en mujeres que se embarazaron durante el tratamiento con cabergolina (CAB). Estimar la frecuencia de patología detectada posnacimiento en los niños producto de dichos embarazos. Material y métodos: Estudio retrospectivo y multicéntrico de 86 embarazos en 78 mujeres con hiperprolactinemia idiopática (7) o tumoral (44 micro y 27 macro), en tratamiento con CAB en el momento de la concepción. Edad: 20 a 45 años; PRL inicial: 30 a 1429 ng/ml; duración del tratamiento previo al embarazo 1 a 120 meses; dosis: 0.125 a 4 mg/semana. El rango de exposición embriofetal a la CAB fue de 3 a 27 semanas, el 96.39% de las pacientes la recibió durante el primer trimestre y el 3.61% hasta el segundo. Resultados: No hubo complicaciones mayores durante el embarazo. Se registraron 7 abortos espontáneos (8.1%) y 75 partos, de los cuales 49 fueron vaginales y 26 cesáreas. Se registraron 69 recién nacidos, 63 fueron a término y 6 pretérmino (8.8%), ninguno bajo peso para la edad gestacional. En 3 (5.2%) recién nacidos se observó: 1 malformación mayor (Síndrome de Down) y 2 menores (hernia umbilical e inguinal). Se obtuvo seguimiento de 42 recién nacidos; se diagnosticó epilepsia refractaria en uno y un trastorno generalizado del desarrollo en otro. No se halló una mayor frecuencia de complicaciones en los embarazos ni en los recién nacidos expuestos a CAB que en la población normal. Sería necesario mayor número de pacientes para concluir sobre la seguridad de CAB durante el embarazo.

Objectives: To assess the rate of any potential adverse effects on pregnancy and embryo-fetal development in women who became pregnant under treatment with cabergoline (CAB). To follow up medical data of children who were born from mothers exposed to Cab in early weeks of gestation. Material and methods: Observational, retrospective and multicenter study on 86 pregnancies in 78 women with idiopathic or tumoral hyperprolactinemia. All patients were under Cab at conception. The average age was 29 (range: 20-45). Pituitary images at diagnosis showed 44 microadenomas, 27 macroadenomas and 7 were normal. Serum PRL at baseline was between 30 and 1429 ng/ml. Duration of therapy before pregnancy ranged from 1 to 120 months. Maternal and fetal exposure to cabergoline and doses ranged from 0.125 to 4 mg/week. The mean serum PRL level under which patients achieved pregnancy was 17 ng/ml. Fetal exposure ranged from 3 to 27 weeks; 96.39% of patients received CAB during the first trimester of pregnancy and 3.61% until the second one. Results: No significant complications during pregnancy were found. Seven women (8.1%) had spontaneous abortions. Term deliveries were recorded in 63/69, preterm in six (8.8%), none of them with low weight for gestational age. Neonatal abnormalities were observed in 3 (5.2%): 1 major (Down syndrome) and 2 minor malformations (umbilical and inguinal hernia). Two out of 42, developed abnormalities during the follow- up, one of them was a refractory epilepsy during the second month of life, the other presented a Pervasive Developmental Disorder diagnosed in the third year of life. Conclusion: No significantly higher frequency of complications was found in pregnancies and/or offspring exposed to CAB than in normal population. Larger series of patients are needed to asses the safety.

Evaluation and analysis of patient outcomes with an intrasegmental fixation system in lumbar spinal fusion.

BACKGROUND CONTEXT: A new spinal fixation system with polydirectional screws and modular links with interconnecting radial serrations has been developed. The system allows the linking of multiple points of fixation, two points at a time (intrasegmental fixation), thus eliminating the need for intraoperative contouring of rods or plates. PURPOSE: Evaluation of this new type of spine system was done through biomechanical studies, analysis of lumbar lordosis preservation postoperatively, and multicenter review of patient outcomes with a minimum of 1 year follow-up. STUDY DESIGN/SETTING: Biomechanical studies of the spine system were performed according to American Society for Testing and Materials (ASTM) standards. To evaluate the maintenance of lordosis, radiographs from the first 119 patients were reviewed by the authors. Analysis of patient outcomes consisted of a review of the first 259 patients who underwent spinal fusion surgery with the new spine system. PATIENT SAMPLE: Evaluation of patient outcomes consisted of 122 men and 137 women with an average age of 50+/-13 years (range, 22-96 years) and a mean follow-up of 20+/-6 months (range, 12-54 months). The patient population was at high risk for fusion failure, with 127 smokers (49%), 141 who had previous spine surgery (54%), 22 with osteoporosis (8%), 63 were obese (24%), and 32 with diabetes (12%). One hundred two patients (39%) had a one-level fusion, 105 patients (41%) had two levels fused, and 52 patients (20%) had three or more levels fused. The majority of patients (66%) were covered under workers' compensation. OUTCOME MEASURES/METHODS: Radiographic fusion was deemed successful when the presence of trabecular bridging bone from transverse process to transverse process was observed, as well as no fixation failure nor radiographic evidence of screw loosening. Clinical success was rated excellent, good, fair, or poor depending on the patients pain level, function, and pain medication intake. RESULTS: Biomechanical studies of this intrasegmental fixation system have shown it to be strong under both static and fatigue testing, with exceptional strength in compression bending. In evaluating preservation of lumbar lordosis, no statistically significant loss of lordosis was observed. Overall, radiographic fusion was noted in 229 of 259 patients (88%) and did not differ significantly (p>.10) by the number of levels fused. Clinically, 69 patients (27%) had an excellent result, 111 patients (43%) had a good result, 50 patients (19%) had a fair result, and 29 patients (11%) had a poor result. The high rate of successful patient outcomes did not differ significantly (p>.10) by the number of levels fused, or other patient or surgical variables, except for the satisfaction level of workers' compensation versus nonworkers' compensation. One hundred of 118 patients (85%) who were working before surgery returned to work at an average 9+/-4 months postoperatively (range, 2-20 months). The use of direct current (DC) stimulation in this population was reserved for patients with one or more risk factors for fusion failure and was noted to be of benefit. There were no recorded intraoperative complications, but postoperatively 5 device and 19 non-device-related complications (9%) were noted, which is comparable to other lumbar fusion series. CONCLUSIONS: The results of these analyses show consistent patient outcomes regardless of the number of levels fused with an intrasegmental system. This may be attributable to the increased biomechanical strength of the system at each segment, coupled with the ability of intrasegmental fixation to maintain sagittal plane balance through preservation of the patient's lordotic curve.

Relationship between cathepsin-D and other prognostic factors in human breast cancer.

Cathepsin-D (CATH-D) is a lysosomal protease induced by estrogens in estrogen receptor-positive breast cancer call lines and constitutively produced by estrogen receptor-negative breast cancer cells. The concentration of CATH-D in the cytosol of 97 human breast tumor tissues was correlated with other well-known prognostic factors for human breast cancer. CATH-D was significantly higher in node-positive than in node-negative tumors (P = 0.042, Kruskal-Wallis test). However, no correlation was found between enzyme levels and the number of positive nodes. CATH-D concentration did not correlate with age, menopausal status, clinical stage of the disease, size of the primary tumor, steroid receptors, thymidine labeling index, histological grade, nuclear grade or cellularity. CATH-D did not show any association with the known prognostic factors evaluated in this study and its association with lymph nodes was only weak.

Efficacy of implanted bone growth stimulation in instrumented lumbosacral spinal fusion.

STUDY DESIGN: Ninety-four patients were assigned to groups either with or without implanted bone growth stimulation as an adjunct to instrumented animal fusion between May 1990 and December 1992. Consecutive groups with or without stimulation were compared prospectively; a small group was compared with random assignment of surgery with or without stimulation. OBJECTIVE: To test the efficacy of implanted bone growth stimulation in instrumented fusion, especially regarding high-rist patient groups including smokers, those with previous back surgery, and those with multiple fusion levels. SUMMARY OF BACKGROUND DATA: No reports have specifically addressed implanted bone growth stimulation with instrumented spinal fusion, although the effects of stimulation on long-bone and in situ spinal fusion have been reported. METHODS: Fusion surgery was performed by the same two surgeons for all patients, using autologous graft and instrumentation (pedicle screw and rod). Surgical indications and pre- and postoperative regimens were similar for all patients. Average follow-up period was 20.5 months. RESULTS: Ninety-six percent of patients with stimulation had solid fusion versus 85% fusion in patients who did not have stimulation. CONCLUSIONS: Implanted bone growth stimulation can improve fusion results in patients with instrumented lumbosacral fusion as has been demonstrated in in situ fusions. Patients in high-risk categories (smokers, those with multiple back surgeries, and multilevel fusions) also are demonstrated to have higher fusion rates with implanted bone growth stimulation than those without benefit of stimulation.

Uniones específicas a estradiol y progesterona en meningiomas y neurinomas: correlación clínica y con el edema cerebral / Specific binding of estrogen and progesterone in meningiomas and neurinomas: relation to clinical features and brain edema

El predominio de meningiomas (M) en el sexo femenino, la exacerbación de los sintomas durante el embarazo y el mayor grado de crecimiento de los neurinomas (N) en la edad fértil en mujeres sugieren la posible hormonodependencia de estos tumores. Se estudiaron 16 M, pertenecientes a 7 hombres y 9 mujeres y 5 N de mujeres, obtenidos quirúrgicamente y conservados en nitrógeno líquido. Se determinó en ellos la densidad de receptores (R), de acuerdo a la unión específica a estradiol (E) y progesterona (P), con técnica de Carbón Dextrán. Se consideraron positivos valores mayores a 10 fentomoles de hormona unida por miligramo de proteína citosoluble. Se midió además el grado de edema cerebral de los M en la TAC y se lo expresó como el porcentaje de edema cerebral, en relación al parénquima cerebral no comprometido por edema. Once de 16 M tuvieron R positivos para E y 8 de 16 para P. Tres de 5 N tuvieron R positivos para E y 2 de 5 para P. Si bien un 66,6%de los tumores presentaron R a E y 47,6%R a P, no pudo encontrarse relación entre ellos y la edad , sexo, estado menopáusico de las pacientes ni tipo histológico de los tumores. Tampoco se encontró correlación estadísticamente significativa entre el porcentaje de edema y el nivel de R a E y P en los M evaluados. Nuestros resultados evidencian que un alto porcentaje de M y N presentan R positivos a E y P. Desconocemos el significado funcional de los mismos y la falta de correlación con el grado de edema peritumoral no permite relacionar su presencia con la generación del mismo

Uniones específicas a estradiol y progesterona en meningiomas y neurinomas: correlación clínica y con el edema cerebral / Specific binding of estrogen and progesterone in meningiomas and neurinomas: relation to clinical features and brain edema

El predominio de meningiomas (M) en el sexo femenino, la exacerbación de los sintomas durante el embarazo y el mayor grado de crecimiento de los neurinomas (N) en la edad fértil en mujeres sugieren la posible hormonodependencia de estos tumores. Se estudiaron 16 M, pertenecientes a 7 hombres y 9 mujeres y 5 N de mujeres, obtenidos quirúrgicamente y conservados en nitrógeno líquido. Se determinó en ellos la densidad de receptores (R), de acuerdo a la unión específica a estradiol (E) y progesterona (P), con técnica de Carbón Dextrán. Se consideraron positivos valores mayores a 10 fentomoles de hormona unida por miligramo de proteína citosoluble. Se midió además el grado de edema cerebral de los M en la TAC y se lo expresó como el porcentaje de edema cerebral, en relación al parénquima cerebral no comprometido por edema. Once de 16 M tuvieron R positivos para E y 8 de 16 para P. Tres de 5 N tuvieron R positivos para E y 2 de 5 para P. Si bien un 66,6%de los tumores presentaron R a E y 47,6%R a P, no pudo encontrarse relación entre ellos y la edad , sexo, estado menopáusico de las pacientes ni tipo histológico de los tumores. Tampoco se encontró correlación estadísticamente significativa entre el porcentaje de edema y el nivel de R a E y P en los M evaluados. Nuestros resultados evidencian que un alto porcentaje de M y N presentan R positivos a E y P. Desconocemos el significado funcional de los mismos y la falta de correlación con el grado de edema peritumoral no permite relacionar su presencia con la generación del mismo

[Lactate threshold and the physiological cost of work]. / Próg mleczanowy a koszt fizjologiczny pracy.

Mean values for body size, fitness and endurance performance indices have been obtained from 20 industrial workers. Then the pulse rate from ECG using the Holter method during the worktime was registered and from the regression line PF on load energy expenditure was calculated. The "somatic" and "fitness" indices of subjects were not statistically significantly different from average workers population in Poland. The mean AT demonstrated that the subjects were able to perform hard work without metabolic acidosis developing, though those exhibiting lower AT worked with higher physiological cost of work. The study confirmed that the Holter method is extremely good for energy expenditure investigation during the worktime. Furthermore it was demonstrated that the physiological cost of moderate-heavy work was lower in subjects with higher AT. The authors suggested that the level of AT for medium-fit workers should come to about 2 dm3(02) X min.-1 (60%v02 max.

Standards and predicted values of anaerobic threshold.

Mean values for body size, body composition and endurance indices have been obtained from a homogeneous group of 125 physically active men to find predicted values of AT (age 23.4 +/- 4.3 years; height 175.9 +/- 6.5 cm; weight 72.2 +/- 8.9 kg; body fat 17.9 +/- 4.7% body weight, muscularity index 19.0 +/- 1.5 kg fat-free mass/cm2 X 10(-4) height; forced vital lung capacity 5667 +/- 815 cm3; VO2max 48.5 +/- 6.0 cm3 X kg-1 X min-1; anaerobic threshold 61.0 +/- 7.8% VO2max). Endurance performance and fitness indices were a little higher than average, but about 10% lower than in endurance-trained athletes. The authors suggest that standards of anaerobic threshold (AT) for ergonomics and endurance training should be about 55-65% VO2max, but not lower than 1800 cm3 O2 X min-1. The coefficients of correlation of AT relating to VO2max, PFO2 and submaximal load were significant at the 0.01 level. Using regression analysis, predicted values of AT were developed. A predicted value of AT can be obtained from the regression line of AT on Lsubmax used as a nomogram, during a simple PWC170 exercise test without blood or gas analysis.